Rinatra 5 mg (Linagliptin)
Linagliptin 5mg
Tablet · Prescription medication
Bionex Co., Ltd.
MFDS item code 201904712 · Approved 2019.07.12
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone, but it may be combined with metformin when initial treatment is difficult or not adequately manageable with monotherapy. Additionally, it is used in conjunction with metformin or sulfonylurea monotherapy when blood sugar control is difficult. It can also be combined when blood sugar is not adequately controlled with insulin treatment or combined therapy with sulfonylurea and metformin. This medication is added when sufficient blood sugar control is difficult even when combined with empagliflozin and metformin. Thus, this medication effectively improves blood sugar control in various therapeutic situations.
The recommended dose of this medicine is 5mg once daily. It may be taken with or without food. When used in combination with insulin or an insulin secretagogue (e.g., sulfonylureas), lower doses of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.
This medication should not be administered to those who are allergic to its main ingredient or other components. It should also not be used in patients with type 1 diabetes or diabetic ketoacidosis. Additionally, caution is necessary when used with insulin or sulfonylurea drugs, which can cause hypoglycemia, as the risk of hypoglycemia may increase. In particular, in patients with severely impaired kidney function, the risk of hypoglycemia may increase when used in conjunction with insulin, and dose adjustments may be necessary. Since there is limited experience with this medication in patients with heart failure, it should be administered carefully. Furthermore, acute pancreatitis may occur during the use of this medication, so if symptoms such as severe abdominal pain arise, consumption should be stopped immediately and a physician should be consulted. Skin conditions resembling bullous pemphigoid may occur, so if blisters or eruptions appear on the skin, medical personnel should be notified immediately, and if necessary, discontinuation of the medication and consultation with a specialist may be required. During the use of this medication, hypoglycemic symptoms may occur, so it is important to be well aware of hypoglycemic symptoms, especially when combined with other blood sugar-lowering agents. The use of this medication is not recommended for pregnant or nursing women, and nursing mothers should consult with a professional because this medication may be excreted in breast milk. It is advisable not to use this medication in children under 10 years of age, as safety and efficacy have not been established, and adolescents over 10 years of age should use it under the judgment of a physician. In elderly patients, it can be used without special dosage adjustments, and it can also be administered without dose adjustments in patients with impaired kidney or liver function. In the case of overdose, there is no specific antidote, so measures should be taken to prevent the absorption of the medication in the gastrointestinal tract, and symptoms should be observed while receiving necessary treatment. This medication should be stored out of reach of children, and care should be taken not to transfer it to other containers, as this may cause accidents or reduce quality.
Hypoglycemia, pancreatitis, bullous pemphigoid, nasopharyngitis, hypersensitivity, angioedema, urticaria, cough, constipation, oral ulcers, rash, arthralgia accompanied by severity and disability, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, upper abdominal pain, enterocolitis, intestinal obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorder, Alzheimer's dementia, chest pain, fever, facial edema, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscal injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anemia, nausea, diarrhea, vomiting, gastroesophageal reflux disease, gastritis, viral upper respiratory infection, upper respiratory infection, gastroenteritis, herpes zoster, cystitis, dizziness, sensory impairment, chest discomfort, asthenia, pain, epistaxis, oropharyngeal pain, voice disorders, allergic rhinitis, exercise-induced dyspnea, moist cough, rhinorrhea, pulmonary masses, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue masses, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urine albumin/creatinine ratio, positive urine leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased blood creatine phosphokinase activity, increased ALT, increased triglycerides in blood, androgenetic alopecia, hyperhidrosis, hair loss, dermatitis, anxiety, affective disorder, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, laceration, palpitations, dry eyes, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, cholelithiasis, hearing loss, erectile dysfunction, goiter, hypertension, benign prostatic hyperplasia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it must be stored in a tightly sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Storing it this way can help retain its efficacy for a longer period.
Bright red round film-coated tablet
Bottle - 30 tablets/bottle, PTTP - 30 tablets/PTTP [(10 tablets/Alu-Alu X3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 5mg
Tablet · Prescription medication
Bionex Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.